Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Follow-Up Questions
Calithera Biosciences Inc (CALA) の株価収益率はいくらですか？
Calithera Biosciences Inc の株価収益率は 0 です。
Calithera Biosciences Inc のCEOは誰ですか？
Dr. Susan Molineaux は Calithera Biosciences Inc の President で、2010 から在籍しています。
